Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / MPM Bioventures 2022, L.P.

MPM Bioventures 2022, L.P.

Active deploymentUnknownFundADV: Venture Capital FundMPM BioimpactDelaware
Amounts, each with its basis
Vintage
2022basis: name year
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
indefinitewhat may be sold, not what was raised; file 021-444554, sworn by the adviser or filed under this vehicle
Form D sold
$351Mas of the filing of Jun 1, 2023, 45 investors
First sale
May 26, 2022
Reported GAV
$345Mon the Form ADV filed Jun 26, 2024; the fund's assets, never its size or dry powder
Owners (ADV)
40
Reported on ADV
Mar 30, 2023 to Jun 26, 2024
Fundraising evidence
Unknown
latest Form D 2023-06-01, older than 15 months (fr-1)
evidence dated Jun 1, 2023. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Active deployment
vintage 2 to 4 years
age years: 4first sale: 2022-05-26vintage year: $2,022adv gav as of: 2024-06-26vintage basis: name_yearform d sold usd: $351Mform d offering usd: n/aform d latest filed at: 2023-06-01
The fund's own reporting through time
6 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 30, 2023Private Equity Fund$338M
40$3.0M1%yes
Oct 30, 2023Private Equity Fund$338M
40$3.0M1%yes
Mar 28, 2024Private Equity Fund$345M
40$3.0M1%yes
Jun 6, 2024Private Equity Fund$345M
40$3.0M1%yes
Jun 6, 2024Private Equity Fund$345M
40$3.0M1%yes
Jun 26, 2024Venture Capital Fund$345M
40$3.0M1%yes
Principals and agents
3 principals on Form D, 1 placement agents
  • Ansbert Gadicke Executive Officer
  • MPM Bioventures 2022 GP LLC Promoter
  • Luke Evnin Executive Officer
  • J.P. Morgan Securities LLC placement agent
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
3 events
  1. Jun 1, 2023
    MPM BioVentures 2022, L.P. filed Form D/A: $351,010,000 sold (indefinite offering), Private Equity Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Mar 30, 2023
    MPM Bioventures 2022, L.P. first reported on Form ADV by MPM Asset Management LLC (Private Equity Fund), GAV $337,703,600
    Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. May 5, 2022
    MPM BioVentures 2022, L.P. filed Form D: no sales yet (indefinite offering), Private Equity Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
31 observations
Every observation on this vehicle